Elevance Health, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Elevance Health, Inc. (ELV), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are ELV insiders buying or selling?
Elevance Health, Inc. insiders reported 8 open-market buys ($8.1M) and 83 sells ($199.7M) across 91 Form 4 filings — a net selling position of $191.6M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 17, 2026)
Insider sentiment
Net sellingNet insider flow of $191.6M in net selling. 2 insider buys in the last 90 days.
Recent ELV insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | Ramiro G Peru | Director | Purchase | 1.0K | $366.05 | $366.1K |
| Jul 17, 2026 | Gail Boudreaux | President and CEO | Purchase | 2.7K | $367.79 | $1.0M |
| Jun 15, 2026 | Ronald W Penczek | CAO & Controller | Sale | 369 | $403.16 | $148.8K |
| Jun 12, 2026 | Robert L Dixon JR | Director | Sale | 151 | $401.77 | $60.7K |
| May 20, 2026 | Ronald W Penczek | CAO & Controller | Sale | 1.5K | $403.13 | $617.2K |
| Mar 23, 2026 | Amy W Schulman | Director | Sale | 26 | $287.50 | $7.5K |
| Mar 9, 2026 | Charles Morgan Kendrick JR | EVP & President, Commercial | Sale | 3.2K | $284.92 | $910.6K |
| Mar 6, 2026 | Steven H Collis | Director | Purchase | 3.0K | $289.84 | $869.5K |
| Aug 21, 2025 | Susan D. Devore | Director | Purchase | 1.2K | $312.15 | $374.6K |
| Jul 18, 2025 | Gail Boudreaux | President and CEO | Purchase | 8.5K | $286.94 | $2.4M |
| Apr 25, 2025 | Mark Kaye | EVP & CFO | Sale | 4.6K | $424.82 | $1.9M |
| Mar 11, 2025 | Ronald W Penczek | CAO & Controller | Sale | 443 | $415.13 | $183.9K |
| Mar 5, 2025 | Charles Morgan Kendrick JR | EVP & President, Commercial | Sale | 3.5K | $396.30 | $1.4M |
| Oct 18, 2024 | Charles Morgan Kendrick JR | EVP & President, Commercial | Sale | 7.4K | $432.14 | $3.2M |
| Aug 6, 2024 | Ramiro G Peru | Director | Sale | 753 | $531.52 | $400.2K |
| Jul 23, 2024 | Gail Boudreaux | President and CEO | Sale | 34.0K | $500.98 | $17.0M |
| Jul 22, 2024 | Robert L Dixon JR | Director | Sale | 305 | $506.76 | $154.6K |
| Apr 25, 2024 | Felicia F Norwood | EVP & President,Gov Health Ben | Sale | 20.3K | $533.34 | $10.8M |
| Mar 12, 2024 | Charles Morgan Kendrick JR | EVP & President, Commercial | Sale | 2.4K | $500.46 | $1.2M |
| Mar 8, 2024 | Ronald W Penczek | CAO & Controller | Sale | 916 | $504.58 | $462.2K |
| Mar 5, 2024 | Peter D Haytaian | EVP & Pres Carelon & CarelonRx | Sale | 21.1K | $500.18 | $10.6M |
| Feb 9, 2024 | Ramiro G Peru | Director | Sale | 753 | $500.00 | $376.5K |
| Dec 15, 2023 | Blair Williams Todt | EVP, CLO & CAO | Sale | 5.5K | $484.02 | $2.7M |
| Dec 1, 2023 | Ronald W Penczek | CAO & Controller | Sale | 1.1K | $475.17 | $501.3K |
| Oct 26, 2023 | Ronald W Penczek | CAO & Controller | Sale | 64 | $454.35 | $29.1K |
Showing the 25 most recent of 91 Form 4 filings for Elevance Health, Inc..
Most active ELV insiders
- Peter D Haytaian19 filings
- Ronald W Penczek16 filings
- Ramiro G Peru8 filings
- Robert L Dixon JR8 filings
- Julie A Hill7 filings
Ask anything about ELV insider activity
Use Trabud's AI agent to query Elevance Health, Inc.'s Form 4 history in plain English — "Show me ELV CEO purchases this year" or compare it against any other ticker.
Open the AI agentELV insider trading FAQ
Are Elevance Health, Inc. insiders buying or selling?
Across 91 SEC Form 4 filings, Elevance Health, Inc. (ELV) insiders reported 8 open-market purchases totaling $8.1M and 83 sales totaling $199.7M. That is a net selling position of $191.6M.
How many insiders trade ELV stock?
19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Elevance Health, Inc.. The most recent filing was accepted on Jul 17, 2026.
Where does Trabud get ELV insider trading data?
All ELV insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.